1 Study Coverage
1.1 Neisseria meningitidis Infections Drug Product Introduction
1.2 Market Segments
1.3 Key Neisseria meningitidis Infections Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Neisseria meningitidis Infections Drug Market Size Growth Rate by Type
1.4.2 MGBBP-3
1.4.3 NCL-195
1.4.4 TP-10
1.4.5 Others
1.5 Market by Application
1.5.1 Global Neisseria meningitidis Infections Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Neisseria meningitidis Infections Drug Market Size, Estimates and Forecasts
2.1.1 Global Neisseria meningitidis Infections Drug Revenue 2015-2026
2.1.2 Global Neisseria meningitidis Infections Drug Sales 2015-2026
2.2 Global Neisseria meningitidis Infections Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Neisseria meningitidis Infections Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Neisseria meningitidis Infections Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Neisseria meningitidis Infections Drug Competitor Landscape by Players
3.1 Neisseria meningitidis Infections Drug Sales by Manufacturers
3.1.1 Neisseria meningitidis Infections Drug Sales by Manufacturers (2015-2020)
3.1.2 Neisseria meningitidis Infections Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Neisseria meningitidis Infections Drug Revenue by Manufacturers
3.2.1 Neisseria meningitidis Infections Drug Revenue by Manufacturers (2015-2020)
3.2.2 Neisseria meningitidis Infections Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Neisseria meningitidis Infections Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Neisseria meningitidis Infections Drug Revenue in 2019
3.2.5 Global Neisseria meningitidis Infections Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Neisseria meningitidis Infections Drug Price by Manufacturers
3.4 Neisseria meningitidis Infections Drug Manufacturing Base Distribution, Product Types
3.4.1 Neisseria meningitidis Infections Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Neisseria meningitidis Infections Drug Product Type
3.4.3 Date of International Manufacturers Enter into Neisseria meningitidis Infections Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Neisseria meningitidis Infections Drug Market Size by Type (2015-2020)
4.1.1 Global Neisseria meningitidis Infections Drug Sales by Type (2015-2020)
4.1.2 Global Neisseria meningitidis Infections Drug Revenue by Type (2015-2020)
4.1.3 Neisseria meningitidis Infections Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Neisseria meningitidis Infections Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Neisseria meningitidis Infections Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Neisseria meningitidis Infections Drug Revenue Forecast by Type (2021-2026)
4.2.3 Neisseria meningitidis Infections Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Neisseria meningitidis Infections Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Neisseria meningitidis Infections Drug Market Size by Application (2015-2020)
5.1.1 Global Neisseria meningitidis Infections Drug Sales by Application (2015-2020)
5.1.2 Global Neisseria meningitidis Infections Drug Revenue by Application (2015-2020)
5.1.3 Neisseria meningitidis Infections Drug Price by Application (2015-2020)
5.2 Neisseria meningitidis Infections Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Neisseria meningitidis Infections Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Neisseria meningitidis Infections Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Neisseria meningitidis Infections Drug Price Forecast by Application (2021-2026)

6 North America
6.1 North America Neisseria meningitidis Infections Drug by Country
6.1.1 North America Neisseria meningitidis Infections Drug Sales by Country
6.1.2 North America Neisseria meningitidis Infections Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Neisseria meningitidis Infections Drug Market Facts & Figures by Type
6.3 North America Neisseria meningitidis Infections Drug Market Facts & Figures by Application

7 Europe
7.1 Europe Neisseria meningitidis Infections Drug by Country
7.1.1 Europe Neisseria meningitidis Infections Drug Sales by Country
7.1.2 Europe Neisseria meningitidis Infections Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Neisseria meningitidis Infections Drug Market Facts & Figures by Type
7.3 Europe Neisseria meningitidis Infections Drug Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Neisseria meningitidis Infections Drug by Region
8.1.1 Asia Pacific Neisseria meningitidis Infections Drug Sales by Region
8.1.2 Asia Pacific Neisseria meningitidis Infections Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Neisseria meningitidis Infections Drug Market Facts & Figures by Type
8.3 Asia Pacific Neisseria meningitidis Infections Drug Market Facts & Figures by Application

9 Latin America
9.1 Latin America Neisseria meningitidis Infections Drug by Country
9.1.1 Latin America Neisseria meningitidis Infections Drug Sales by Country
9.1.2 Latin America Neisseria meningitidis Infections Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Neisseria meningitidis Infections Drug Market Facts & Figures by Type
9.3 Central & South America Neisseria meningitidis Infections Drug Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Neisseria meningitidis Infections Drug by Country
10.1.1 Middle East and Africa Neisseria meningitidis Infections Drug Sales by Country
10.1.2 Middle East and Africa Neisseria meningitidis Infections Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Neisseria meningitidis Infections Drug Market Facts & Figures by Type
10.3 Middle East and Africa Neisseria meningitidis Infections Drug Market Facts & Figures by Application

11 Company Profiles
11.1 Beijing Minhai Biotechnology Co Ltd
11.1.1 Beijing Minhai Biotechnology Co Ltd Corporation Information
11.1.2 Beijing Minhai Biotechnology Co Ltd Description and Business Overview
11.1.3 Beijing Minhai Biotechnology Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Products Offered
11.1.5 Beijing Minhai Biotechnology Co Ltd Related Developments
11.2 Biological E Ltd
11.2.1 Biological E Ltd Corporation Information
11.2.2 Biological E Ltd Description and Business Overview
11.2.3 Biological E Ltd Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Biological E Ltd Neisseria meningitidis Infections Drug Products Offered
11.2.5 Biological E Ltd Related Developments
11.3 China National Pharmaceutical Group Corp
11.3.1 China National Pharmaceutical Group Corp Corporation Information
11.3.2 China National Pharmaceutical Group Corp Description and Business Overview
11.3.3 China National Pharmaceutical Group Corp Sales, Revenue and Gross Margin (2015-2020)
11.3.4 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Products Offered
11.3.5 China National Pharmaceutical Group Corp Related Developments
11.4 GlaxoSmithKline Plc
11.4.1 GlaxoSmithKline Plc Corporation Information
11.4.2 GlaxoSmithKline Plc Description and Business Overview
11.4.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Products Offered
11.4.5 GlaxoSmithKline Plc Related Developments
11.5 Griffith University
11.5.1 Griffith University Corporation Information
11.5.2 Griffith University Description and Business Overview
11.5.3 Griffith University Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Griffith University Neisseria meningitidis Infections Drug Products Offered
11.5.5 Griffith University Related Developments
11.6 ImmunoBiology Ltd
11.6.1 ImmunoBiology Ltd Corporation Information
11.6.2 ImmunoBiology Ltd Description and Business Overview
11.6.3 ImmunoBiology Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Products Offered
11.6.5 ImmunoBiology Ltd Related Developments
11.7 JN-International Medical Corp
11.7.1 JN-International Medical Corp Corporation Information
11.7.2 JN-International Medical Corp Description and Business Overview
11.7.3 JN-International Medical Corp Sales, Revenue and Gross Margin (2015-2020)
11.7.4 JN-International Medical Corp Neisseria meningitidis Infections Drug Products Offered
11.7.5 JN-International Medical Corp Related Developments
11.8 MGB Biopharma Ltd
11.8.1 MGB Biopharma Ltd Corporation Information
11.8.2 MGB Biopharma Ltd Description and Business Overview
11.8.3 MGB Biopharma Ltd Sales, Revenue and Gross Margin (2015-2020)
11.8.4 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Products Offered
11.8.5 MGB Biopharma Ltd Related Developments
11.9 Panacea Biotec Ltd
11.9.1 Panacea Biotec Ltd Corporation Information
11.9.2 Panacea Biotec Ltd Description and Business Overview
11.9.3 Panacea Biotec Ltd Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Products Offered
11.9.5 Panacea Biotec Ltd Related Developments
11.10 Pfizer Inc
11.10.1 Pfizer Inc Corporation Information
11.10.2 Pfizer Inc Description and Business Overview
11.10.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Pfizer Inc Neisseria meningitidis Infections Drug Products Offered
11.10.5 Pfizer Inc Related Developments
11.1 Beijing Minhai Biotechnology Co Ltd
11.1.1 Beijing Minhai Biotechnology Co Ltd Corporation Information
11.1.2 Beijing Minhai Biotechnology Co Ltd Description and Business Overview
11.1.3 Beijing Minhai Biotechnology Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Products Offered
11.1.5 Beijing Minhai Biotechnology Co Ltd Related Developments
11.12 Serum Institute of India Ltd
11.12.1 Serum Institute of India Ltd Corporation Information
11.12.2 Serum Institute of India Ltd Description and Business Overview
11.12.3 Serum Institute of India Ltd Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Serum Institute of India Ltd Products Offered
11.12.5 Serum Institute of India Ltd Related Developments
11.13 Wellstat Vaccines LLC
11.13.1 Wellstat Vaccines LLC Corporation Information
11.13.2 Wellstat Vaccines LLC Description and Business Overview
11.13.3 Wellstat Vaccines LLC Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Wellstat Vaccines LLC Products Offered
11.13.5 Wellstat Vaccines LLC Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Neisseria meningitidis Infections Drug Market Estimates and Projections by Region
12.1.1 Global Neisseria meningitidis Infections Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Neisseria meningitidis Infections Drug Revenue Forecast by Regions 2021-2026
12.2 North America Neisseria meningitidis Infections Drug Market Size Forecast (2021-2026)
12.2.1 North America: Neisseria meningitidis Infections Drug Sales Forecast (2021-2026)
12.2.2 North America: Neisseria meningitidis Infections Drug Revenue Forecast (2021-2026)
12.2.3 North America: Neisseria meningitidis Infections Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Neisseria meningitidis Infections Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Neisseria meningitidis Infections Drug Sales Forecast (2021-2026)
12.3.2 Europe: Neisseria meningitidis Infections Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Neisseria meningitidis Infections Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Neisseria meningitidis Infections Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Neisseria meningitidis Infections Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Neisseria meningitidis Infections Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Neisseria meningitidis Infections Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Neisseria meningitidis Infections Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Neisseria meningitidis Infections Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Neisseria meningitidis Infections Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Neisseria meningitidis Infections Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Neisseria meningitidis Infections Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Neisseria meningitidis Infections Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Neisseria meningitidis Infections Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Neisseria meningitidis Infections Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Neisseria meningitidis Infections Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Neisseria meningitidis Infections Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer